DSPE-PEG1000-CCK8

CCCCCCCCCCCCCCCCCC(OC[C@@]([H])(OC(CCCCCCCCCCCCCCCCC)=O)COP(O)(OCCNC(OCCOCCC(N[C@@H](CC(O)=O)C(N[C@H](C(N[C@@H](CCSC)C(NCC(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@H](C(N[C@@H](CC(O)=O)C(N[C@H](C(N)=O)CC3=CC=CC=C3)=O)=O)CCSC)=O)=O)=O)=O)CC4=CC=C(OS(=O)(O)=O)C=C4)=O)=O)=O)=O)=O.[n]

[1]Laverman P, et al. Targeting of a CCK (2) receptor splice variant with (111) In-labelled cholecystokinin-8 (CCK8) and (111) In-labelled minigastrin. Eur J Nucl Med Mol Imaging. 2008 Feb;35 (2) :386-92.